In this volume, we discuss the potential benefits of melatonin in reducing self-harm risk among female youth with depression and anxiety, the sobering reality of racial disparities in pediatric psychotropic prescriptions, and the safety and tolerability of cariprazine, a promising option for pediatric patients with schizophrenia and bipolar I disorder. Also, how does stimulant treatment impact the growth trajectories of children with ADHD? Delve into the debate surrounding the effects of height, and learn when it is best to consider tapering off medication or incorporating drug holidays.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-11-2750?utm_source=PDF+CME+Program&utm_medium=PDF+CME+Program&utm_campaign=PDF+CME+Program
- Start Date: 2023-06-01 05:00:00
- End Date: 2023-06-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest